Ionomycin calcium
Based on 130 publication(s) in Google Scholar
Ionomycin calcium (SQ23377 calcium) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin calcium (SQ23377 calcium) is highly specific for divalent cations (Ca>Mg>Sr=Ba). Ionomycin (SQ23377) promotes apoptosis. Ionomycin calcium (SQ23377 calcium) also induces the activation of protein kinase C (PKC).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 98.32%
- CAS No.: 56092-82-1
- 화학식: C41H70CaO9
- 분자량:747.07
-
보관:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
-
Anti-Infection Compound Library
HY-L002
-
Apoptosis Compound Library
HY-L003
-
Epigenetics Compound Library
HY-L005
-
Immunology/Inflammation Compound Library
HY-L007
-
Membrane Transporter/Ion Channel Compound Library
HY-L011
-
Neuronal Signaling Compound Library
HY-L013
-
TGF-beta/Smad Compound Library
HY-L018
-
Natural Product Library
HY-L021
-
Anti-Cancer Compound Library
HY-L025
-
Oxygen Sensing Compound Library
HY-L045
-
Antibacterial Compound Library
HY-L049
-
Cytoskeleton Compound Library
HY-L060
-
Antibiotics Library
HY-L067
-
Exosomes Compound Library
HY-L072
-
Microbial Metabolite Library
HY-L084
-
Anti-Cancer Natural Product Library
HY-L107
-
Coagulation and Anti-coagulation Compound Library
HY-L136
-
Heterocyclic Compound Library
HY-L138
-
Membrane Protein-targeted Compound Library
HY-L149
-
Membrane Receptor-targeted Compound Library
HY-L150
-
Highly Selective Inhibitors Library
HY-L158
-
Highly Selective Activators Library
HY-L159
-
Cell Death Library
HY-L162
-
Ion Channel Compound Library
HY-L166
-
Extracellular Vesicles (EVs) Compound Library
HY-L168
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
Bioactive Compound Library
HY-L001
-
Protein Kinase Compound Library
HY-L196
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Natural Product Diversity Scaffold Library
HY-L245
-
Mass Spectrometry Natural Product Library
HY-L262
Publications Citing Use of MedChemExpress (MCE) Ionomycin calcium
More- Cancer Cell. 2023 Jun 12;41(6):1170-1185.e12. [Abstract]
- Cell. 2025 Dec 11;188(25):7291-7308.e23. [Abstract]
- Cancer Discov. 2025 Dec 4. [Abstract]
- Cell Metab. 2024 Jun 18:S1550-4131(24)00189-X. [Abstract]
- Nat Cancer. 2025 May;6(5):768-785. [Abstract]
- Cell Res. 2025 Feb;35(2):97-116. [Abstract]
- Cancer Commun (Lond). 2022 Jan;42(1):17-36. [Abstract]
- Cell Stem Cell. 2025 Mar 20:S1934-5909(25)00084-0. [Abstract]
- Cell Mol Immunol. 2026 May;23(5):491-504. [Abstract]
- Cell Mol Immunol. 2026 Apr;23(4):349-366. [Abstract]
- Cell Mol Immunol. 2022 Apr;19(4):540-553. [Abstract]
- Adv Funct Mater. 2025 May 22.
- Cell Host Microbe. 2025 Jun 11;33(6):915-931.e9. [Abstract]
- Cancer Res. 2024 Dec 16;84(24):4199-4213. [Abstract]
- Cancer Res. 2023 Mar 15;83(6):906-921. [Abstract]
- Mol Cell. 2022 Jul 7;82(13):2401-2414.e9. [Abstract]
- Nat Commun. 2025 Nov 24;16(1):10384. [Abstract]
- Nat Commun. 2025 Mar 19;16(1):2728. [Abstract]
- Nat Commun. 2023 Feb 23;14(1):1020. [Abstract]
- Cell Death Differ. 2026 Jan 24. [Abstract]
- Cell Death Differ. 2025 Apr 16. [Abstract]
- Acta Pharm Sin B. 2024 Oct;14(10):4360-4377. [Abstract]
- Sci Transl Med. 2020 Nov 25;12(571):eaaz6667. [Abstract]
- Adv Sci (Weinh). 2026 May;13(29):e17666. [Abstract]
- Adv Sci (Weinh). 2026 Apr 24:e19955. [Abstract]
- Adv Sci (Weinh). 2025 Sep 15:e10102. [Abstract]
- Adv Sci (Weinh). 2025 Jun 19:e00225. [Abstract]
- Adv Sci (Weinh). 2024 Jul;11(26):e2400297. [Abstract]
- Adv Sci (Weinh). 2024 May;11(19):e2306378. [Abstract]
- Adv Sci (Weinh). 2023 Mar;10(7):e2203869. [Abstract]
- J Clin Invest. 2025 Aug 1;135(15):e191119. [Abstract]
- Theranostics. 2025 May 25;15(13):6329-6346. [Abstract]
- Theranostics. 2023 May 8;13(9):2879-2895. [Abstract]
- Protein Cell. 2022 Apr;13(4):281-301. [Abstract]
- J Nanobiotechnology. 2024 Sep 12;22(1):556. [Abstract]
- Redox Biol. 2023 Dec:68:102959. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2410474. [Abstract]
- EBioMedicine. 2024 Aug 6:106:105269. [Abstract]
- Cell Rep Med. 2026 Jun 16;7(6):102833. [Abstract]
- J Immunother Cancer. 2025 Jul 31;13(7):e012029. [Abstract]
- J Immunother Cancer. 2024 Dec 9;12(12):e009910. [Abstract]
- Int J Biol Sci. 2026 Jan 15;22(4):1834-1851. [Abstract]
- Cell Death Dis. 2025 Apr 15;16(1):301. [Abstract]
- Cell Death Dis. 2021 Apr 1;12(4):336. [Abstract]
- Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):e2114851119. [Abstract]
- Int J Biol Macromol. 2023 Jul 31:244:125373. [Abstract]
- Acta Pharmacol Sin. 2023 Apr;44(4):811-821. [Abstract]
- Phytomedicine. 2026 Jun:155:158130. [Abstract]
- Phytomedicine. 2025 Jun 20:145:157017. [Abstract]
- BMC Med. 2025 Mar 31;23(1):189. [Abstract]
- BMC Med. 2023 Dec 20;21(1):507. [Abstract]
- Cancer Immunol Res. 2026 May 4;14(5):875-891. [Abstract]
- Cancer Immunol Res. 2025 Dec 9. [Abstract]
- Cancer Immunol Res. 2025 Jul 2;13(7):1037-1052. [Abstract]
- Sci Total Environ. 2021 Jul 20:779:146523. [Abstract]
- J Transl Med. 2025 Nov 14;23(1):1289. [Abstract]
- J Transl Med. 2024 Dec 20;22(1):1125. [Abstract]
- Biomed Pharmacother. 2024 May:174:116551. [Abstract]
- Biomed Pharmacother. 2022 Mar:147:112644. [Abstract]
- Cell Rep. 2025 Sep 1;44(9):116139. [Abstract]
- Cell Rep. 2025 Jun 13;44(6):115851. [Abstract]
- Cell Rep. 2025 Jun 12;44(6):115857. [Abstract]
- Cell Rep. 2024 Mar 23;43(4):114003. [Abstract]
- Cell Rep. 2021 Jul 20;36(3):109404. [Abstract]
- Antioxidants (Basel). 2026 Mar 25;15(4):413. [Abstract]
- Sci Signal. 2023 Feb 28;16(774):eadd0645. [Abstract]
- Mol Med. 2024 Jul 30;30(1):110. [Abstract]
- OncoImmunology. 2023 Oct 12;12(1):2268257. [Abstract]
- EMBO Rep. 2025 Nov 17. [Abstract]
- Cell Mol Life Sci. 2025 May 28;82(1):218. [Abstract]
- Hum Reprod. 2024 Apr 3;39(4):658-673. [Abstract]
- Ecotoxicol Environ Saf. 2024 Jan 15:270:115831. [Abstract]
- Food Biosci. 2026 Mar 23.
- Front Immunol. 2026 Jan 14:16:1684836. [Abstract]
- Front Immunol. 2022 Aug 5:13:918241. [Abstract]
- Biochem Pharmacol. 2025 Dec;242(Pt 3):117406. [Abstract]
- Biochem Pharmacol. 2024 Jan:219:115957. [Abstract]
- Virulence. 2025 Oct 28:2580150. [Abstract]
- J Ethnopharmacol. 2023 Mar 1:303:116031. [Abstract]
- PLoS Pathog. 2025 Nov 14;21(11):e1013686. [Abstract]
- Int J Mol Sci. 2025 Jun 1;26(11):5332. [Abstract]
- Int J Mol Sci. 2025 May 20;26(10):4913. [Abstract]
- PLoS Pathog. 2025 Feb 4;21(2):e1012912. [Abstract]
- Int J Mol Sci. 2023 Aug 8;24(16):12557. [Abstract]
- Int Immunopharmacol. 2026 Jun 15:179:116583. [Abstract]
- Int Immunopharmacol. 2025 Dec 27:170:116081. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115803. [Abstract]
- Int Immunopharmacol. 2025 May 20:159:114897. [Abstract]
- Int Immunopharmacol. 2024 Sep 16;142(Pt B):113170. [Abstract]
- Int Immunopharmacol. 2024 Jan 5:126:111212. [Abstract]
- Int Immunopharmacol. 2023 Sep 1;124(Pt A):110865. [Abstract]
- Eur J Pharmacol. 2022 Feb 5:916:174623. [Abstract]
- Microorganisms. 2026 Jun 15;14(6):1339. [Abstract]
- J Cell Mol Med. 2025 Oct;29(20):e70915. [Abstract]
- J Cell Mol Med. 2025 Feb;29(3):e70403. [Abstract]
- J Cell Mol Med. 2024 Aug;28(15):e18589. [Abstract]
- Microorganisms. 2023 Feb 27;11(3):604. [Abstract]
- J Inflamm Res. 2025 Dec 10:18:17253-17269. [Abstract]
- iScience. 2025 May 13;28(7):112658. [Abstract]
- Cell Calcium. 2026 Mar:134:103122. [Abstract]
- Cell Calcium. 2022 Jun;104:102571. [Abstract]
- Sci Rep. 2026 Jun 3. [Abstract]
- Fish Shellfish Immunol. 2024 Nov:154:109975. [Abstract]
- Fish Shellfish Immunol. 2024 May:148:109515. [Abstract]
- Oncol Rep. 2024 Feb;51(2):29. [Abstract]
- Aging. 2021 Jun 2;13(11):15638-15658. [Abstract]
- Aging (Albany NY). 2021 Mar 24;13(7):10312-10325. [Abstract]
- Aging. 2019 Aug 19;11(16):6490-6502. [Abstract]
- J Periodontol. 2025 Apr;96(4):355-368. [Abstract]
- ACS Infect Dis. 2023 Apr 14;9(4):979-992. [Abstract]
- J Cell Sci. 2025 Nov 17:jcs.264186. [Abstract]
- Exp Cell Res. 2026 Aug 1;461(1):115103. [Abstract]
- Eur J Med Res. 2025 May 12;30(1):378. [Abstract]
- Vaccines. 2023 May 25;11(6):1026. [Abstract]
- J Immunol. 2021 Mar 1;206(5):963-977. [Abstract]
- Vet Microbiol. 2025 Apr 23:305:110529. [Abstract]
- J Neuroimmunol. 2020 Aug 15;345:577286. [Abstract]
- Immunobiology. 2024 Nov;229(6):152854. [Abstract]
- Arch Oral Biol. 2024 Jul 3:166:106043. [Abstract]
- Reprod Fert Develop. 33(2) 108-108.
- Cytotechnology. 2024 Aug;76(4):465-482. [Abstract]
- Cutan Ocul Toxicol. 2026 Jun;45(2):243-250. [Abstract]
- Cell Insight. 2026 Apr 2;5(3):100323. [Abstract]
- SSRN. 2026 Jan 7.
- SSRN. 2025 Jul 24.
- Preprints. 2025 Feb 12.
- Research Square Preprint. 2023 Aug 11.
- Preprints. 2023 Mar 6.
- Research Square Print. 2022 Jun.
- Evid Based Complement Alternat Med. 2021 Jan 6:2021:8868527. [Abstract]
Customer Validation & Images
-
RT-PCR
-
Flow Cytometry
-
Cell Imaging/Staining
-
Cell Imaging/Staining
-
IF
All Calcium Channel Isoforms
MoreAll Antibiotic Isoforms
More
Biological Activity
Calcium ionophore[1]
Ionomycin is a Calcium ionophore and an antibiotic produced by Streptomyces conglobatus[1].
Addition of 2 μM Ionomycin to LCLC 103H cells causes an instantaneous increase in intracellular Ca2+ concentration from 50 to 180 nM. DNA and protein analysis in Ionomycin-treated cultures revealed DNA fragmentation and PARP cleavage to an 85-kDa fragment typical of caspase-mediated apoptosis. Necrosis could be detected in ~1-5% of the Ionomycin treated cells. Caspase activation in whole cells was followed by monitoring the increase in activity against Ac-DEVD-amc following Ionomycin treatment[2].
Ionomycin-mediated cleavage and exosome release. Following Ionomycin exposure, medium conditioned by SKOV3ip cells had increased amounts of exosomes containing the L1-32 cleavage fragment[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 56092-82-1
-
Appearance Solid
-
분자량 747.07
-
화학식 C41H70CaO9
-
Color White to off-white
-
SMILES
O=C([O-])CC[C@@H](C)C[C@H](C)C[C@H](C)C(/C=C([O-])/[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)C[C@@H]1CC[C@]([C@@H]2O[C@](C)([C@H](O)C)CC2)(C)O1)=O.[Ca+2]
-
Synonyms
SQ23377 calcium
-
Structure Classification
-
Initial Source
Streptomyces conglobatus
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (130)
-
Journal Impact Factor
-
Most Recent
-
Cancer Cell
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity. [Abstract]2023 Jun 12;41(6):1170-1185.e12. PMID: 37311414 -
Cell
2025 Dec 11;188(25):7291-7308.e23. PMID: 41161316 -
Cancer Discov
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model. [Abstract]2025 Dec 4. PMID: 41342739 -
Cell Metab
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer. [Abstract]2024 Jun 18:S1550-4131(24)00189-X. PMID: 38897198 -
Nat Cancer
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. [Abstract]2025 May;6(5):768-785. PMID: 40108413 -
Cell Res
Nonenzymatic lysine D-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses. [Abstract]2025 Feb;35(2):97-116. PMID: 39757301 -
Cancer Commun (Lond)
Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer. [Abstract]2022 Jan;42(1):17-36. PMID: 34981670 -
Cell Stem Cell
Vagal pathway activation links chronic stress to decline in intestinal stem cell function. [Abstract]2025 Mar 20:S1934-5909(25)00084-0. PMID: 40120585 -
Cell Mol Immunol
MAIT cell plasticity generates CD4+ MAIT cells that promote HCC progression via metabolic crosstalk with tumor cells. [Abstract]2026 May;23(5):491-504. PMID: 41974917 -
Cell Mol Immunol
Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen. [Abstract]2026 Apr;23(4):349-366. PMID: 41781696 -
Cell Mol Immunol
2022 Apr;19(4):540-553. PMID: 35194174 -
-
Cell Host Microbe
Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. [Abstract]2025 Jun 11;33(6):915-931.e9. PMID: 40441145 -
Cancer Res
Inhibition of JNK Signaling Overcomes Cancer-Associated Fibroblast-Mediated Immunosuppression and Enhances the Efficacy of Immunotherapy in Bladder Cancer. [Abstract]2024 Dec 16;84(24):4199-4213. PMID: 39292817 -
Cancer Res
Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Anti-Tumor Immunity. [Abstract]2023 Mar 15;83(6):906-921. PMID: 36634207
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: Cancer Res. 2023 Mar 15;83(6):906-921. [Abstract]
The expression of IFNγ or TNFα in CD8+ T cells isolated from B16 tumors was analyzed after re-stimulation by PMA, Ionomycin (500 ng/mL), and BFA for 4 hours in vitro.
-
Mol Cell
Localization of a TORC1-eIF4F translation complex during CD8+ T cell activation drives divergent cell fate. [Abstract]2022 Jul 7;82(13):2401-2414.e9. PMID: 35597236
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: Mol Cell. 2022 Jul 7;82(13):2401-2414.e9. [Abstract]
Representative images of undivided OT-I CD8+ T cells activated on slides coated with anti-CD3, anti-CD28, and ICAM1 or with PMA plus Ionomycin (1 μM) for 2 h.
-
Nat Commun
Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. [Abstract]2025 Nov 24;16(1):10384. PMID: 41285849 -
Nat Commun
2025 Mar 19;16(1):2728. PMID: 40108208 -
Nat Commun
THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic β-cell function and preserving β-cell mass. [Abstract]2023 Feb 23;14(1):1020. PMID: 36823211 -
Cell Death Differ
CARM1-mediated hypoxanthine-enriched exosomes rewire inosine metabolism and impair CD8+ T cell antitumor function. [Abstract]2026 Jan 24. PMID: 41580530 -
Cell Death Differ
2025 Apr 16. PMID: 40240520 -
Acta Pharm Sin B
Macrophage P2Y6R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses. [Abstract]2024 Oct;14(10):4360-4377. PMID: 39525587 -
Sci Transl Med
Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. [Abstract]2020 Nov 25;12(571):eaaz6667. PMID: 33239389 -
Adv Sci (Weinh)
KCNJ2 is Required for NLRP3 Inflammasome Activation That Drives Allergic Airway Inflammation and Remodeling. [Abstract]2026 May;13(29):e17666. PMID: 41960844 -
Adv Sci (Weinh)
O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer. [Abstract]2026 Apr 24:e19955. PMID: 42028629 -
Adv Sci (Weinh)
Thermosensory TRPV Heterotetramers Drive Seasonal Polyphenism: Molecular Basis of CcIav/CcNan-PKCα-AKH/AKHR Signaling in Pear Psyllid Morph Transition. [Abstract]2025 Sep 15:e10102. PMID: 40953294
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 15:e10102. [Abstract]
CcPKCα modulation by Ionomycin (1 μM in 0.1% DMSO)
-
Adv Sci (Weinh)
Nanoparticle-Mediated CXCL12-CXCR4 Inhibition Reprograms Macrophages and Suppresses Gastric Carcinoma. [Abstract]2025 Jun 19:e00225. PMID: 40536774 -
Adv Sci (Weinh)
Mitochondria-Targeted Nanoadjuvants Induced Multi-Functional Immune-Microenvironment Remodeling to Sensitize Tumor Radio-Immunotherapy. [Abstract]2024 Jul;11(26):e2400297. PMID: 38704675 -
Adv Sci (Weinh)
2024 May;11(19):e2306378. PMID: 38482749 -
Adv Sci (Weinh)
MCU Upregulation Overactivates Mitophagy by Promoting VDAC1 Dimerization and Ubiquitination in the Hepatotoxicity of Cadmium. [Abstract]2023 Mar;10(7):e2203869. PMID: 36642847
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2023 Mar;10(7):e2203869. [Abstract]
Ionomycin (10 μM) served as the positive drug quenching mitochondrial calcein fluorescence.
-
J Clin Invest
2025 Aug 1;135(15):e191119. PMID: 40759573 -
Theranostics
2025 May 25;15(13):6329-6346. PMID: 40521193 -
Theranostics
Disulfiram with Cu2+ alleviates dextran sulfate sodium-induced ulcerative colitis in mice. [Abstract]2023 May 8;13(9):2879-2895. PMID: 37284442 -
Protein Cell
Drug target inference by mining transcriptional data using a novel graph convolutional network framework. [Abstract]2022 Apr;13(4):281-301. PMID: 34677780
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: Protein Cell. 2022 Apr;13(4):281-301. [Abstract]
Jurkat T cells were treated with different concentration of NFV or CsA for 2 h, following stimulation with PMA (100 nmol/L) and Ionomycin (10 μmol/L) for 24 h. After treatment, cells and culture supernatant were collected and subjected to RT-qPCR.
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: Protein Cell. 2022 Apr;13(4):281-301. [Abstract]
Jurkat T cells were treated with different concentration of NFV or CsA for 2 h, following stimulation with PMA (100 nmol/L) and Ionomycin (10 μmol/L) for 24 h. After treatment, cells and culture supernatant were collected and subjected to ELISA.
-
J Nanobiotechnology
A novel spherical GelMA-HAMA hydrogel encapsulating APET×2 polypeptide and CFIm25-targeting sgRNA for immune microenvironment modulation and nucleus pulposus regeneration in intervertebral discs. [Abstract]2024 Sep 12;22(1):556. PMID: 39267105 -
Redox Biol
A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer. [Abstract]2023 Dec:68:102959. PMID: 37977042 -
Gut Microbes
Synergistic activity of Enterococcus Faeciu m-induced ferroptosis via expansion of IFN-γ+CD8+ T cell population in advanced hepatocellular carcinoma treated with sorafenib. [Abstract]2024 Jan-Dec;16(1):2410474. PMID: 39353096 -
EBioMedicine
A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice. [Abstract]2024 Aug 6:106:105269. PMID: 39111250 -
Cell Rep Med
Fungal metabolite-based immunotherapy overcomes tumor-associated macrophage immunosuppression. [Abstract]2026 Jun 16;7(6):102833. PMID: 42173096 -
J Immunother Cancer
Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. [Abstract]2025 Jul 31;13(7):e012029. PMID: 40744664 -
J Immunother Cancer
CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy. [Abstract]2024 Dec 9;12(12):e009910. PMID: 39653553 -
Int J Biol Sci
Abnormal mechanical load aggravates subchondral bone remodeling and uneven tibial plateau settlement in knee osteoarthritis via activation of osteoblast Piezo1-Ca²⁺-JAK2/STAT3 signaling. [Abstract]2026 Jan 15;22(4):1834-1851. PMID: 41694589 -
Cell Death Dis
FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas. [Abstract]2025 Apr 15;16(1):301. PMID: 40234389 -
Cell Death Dis
RANK promotes colorectal cancer migration and invasion by activating the Ca2+-calcineurin/NFATC1-ACP5 axis. [Abstract]2021 Apr 1;12(4):336. PMID: 33795653 -
Proc Natl Acad Sci U S A
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. [Abstract]2022 Feb 22;119(8):e2114851119. PMID: 35181605 -
Int J Biol Macromol
Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease. [Abstract]2023 Jul 31:244:125373. PMID: 37327932 -
Acta Pharmacol Sin
TRPV4 channel is involved in HSV-2 infection in human vaginal epithelial cells through triggering Ca2+ oscillation. [Abstract]2023 Apr;44(4):811-821. PMID: 36151392 -
Phytomedicine
Ellagic acid alleviates ulcerative colitis in a GPR35-dependent manner associated with SDH restoration. [Abstract]2026 Jun:155:158130. PMID: 41936171 -
Phytomedicine
Cucurbitacin B stimulates PD-1 immunotherapy response in malignant breast cancer by covalent targeting MTCH2. [Abstract]2025 Jun 20:145:157017. PMID: 40582210 -
BMC Med
Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8+T-cell subpopulations. [Abstract]2025 Mar 31;23(1):189. PMID: 40165248 -
BMC Med
Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease. [Abstract]2023 Dec 20;21(1):507. PMID: 38124139 -
Cancer Immunol Res
CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer. [Abstract]2026 May 4;14(5):875-891. PMID: 41686262 -
Cancer Immunol Res
2025 Dec 9. PMID: 41364085 -
Cancer Immunol Res
METTL3 Inhibition Restores PD-L1 Expression and CD8+ T-cell Cytotoxic Function in Immunotherapy-Treated Gastric Cancer. [Abstract]2025 Jul 2;13(7):1037-1052. PMID: 40299705 -
Sci Total Environ
2021 Jul 20:779:146523. PMID: 34030247 -
J Transl Med
MPTP mediated Ox-mtDNA release inducing macrophage pyroptosis and exacerbating MCD-induced MASH via promoting the ITPR3/Ca2+/NLRP3 pathway. [Abstract]2025 Nov 14;23(1):1289. PMID: 41239426 -
J Transl Med
Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages. [Abstract]2024 Dec 20;22(1):1125. PMID: 39707412 -
Biomed Pharmacother
Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis. [Abstract]2024 May:174:116551. PMID: 38636399 -
Biomed Pharmacother
Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice by targeting Langerhans cells. [Abstract]2022 Mar:147:112644. PMID: 35051865 -
Cell Rep
SLC6A8-mediated creatine uptake suppresses ERK2-FSP1 signaling and induces ferroptosis in colorectal cancer. [Abstract]2025 Sep 1;44(9):116139. PMID: 40892544 -
Cell Rep
ENPP1 governs the metabolic regulation of effector T cells in autoimmunity by detecting cytosolic mitochondrial DNA. [Abstract]2025 Jun 13;44(6):115851. PMID: 40516055 -
Cell Rep
Maternal vitamin D regulates the metabolic rearrangement of offspring CD4+ T cells in response to intestinal inflammation. [Abstract]2025 Jun 12;44(6):115857. PMID: 40512616 -
Cell Rep
Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity. [Abstract]2024 Mar 23;43(4):114003. PMID: 38527062 -
Cell Rep
TRESK channel contributes to depolarization-induced shunting inhibition and modulates epileptic seizures. [Abstract]2021 Jul 20;36(3):109404. PMID: 34289346 -
Antioxidants (Basel)
Alpha-Lipoic Acid Inhibits IFN-γ-Induced PD-L1 Expression in Prostate Cancer Cells and Enhances T-Cell-Mediated Anti-Tumor Cytotoxicity. [Abstract]2026 Mar 25;15(4):413. PMID: 42072056 -
Sci Signal
IHH, SHH, and primary cilia mediate epithelial-stromal cross-talk during decidualization in mice. [Abstract]2023 Feb 28;16(774):eadd0645. PMID: 36853961 -
Mol Med
Th1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages. [Abstract]2024 Jul 30;30(1):110. PMID: 39080527 -
OncoImmunology
Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltration. [Abstract]2023 Oct 12;12(1):2268257. PMID: 37849962 -
EMBO Rep
2025 Nov 17. PMID: 41249580 -
Cell Mol Life Sci
Dual phosphorylation of glycogen synthase kinase 3β differentially integrates metabolic programs to determine T cell immunity across vertebrates. [Abstract]2025 May 28;82(1):218. PMID: 40434714 -
Hum Reprod
Both protein and non-protein components in extracellular vesicles of human seminal plasma improve human sperm function via CatSper-mediated calcium signaling. [Abstract]2024 Apr 3;39(4):658-673. PMID: 38335261 -
Ecotoxicol Environ Saf
Aluminum-maltol induced oxidative stress and reduced AMPK activity via BCK-related energy supply failure in C6 cell. [Abstract]2024 Jan 15:270:115831. PMID: 38101974 -
-
Front Immunol
Macrophage TRIM21 lactylation exacerbates infection-induced orchitis through enhancing STAT1-mediated CXCL9 and CXCL10 production. [Abstract]2026 Jan 14:16:1684836. PMID: 41613144 -
Front Immunol
DMGV Is a Rheostat of T Cell Survival and a Potential Therapeutic for Inflammatory Diseases and Cancers. [Abstract]2022 Aug 5:13:918241. PMID: 35990633 -
Biochem Pharmacol
Macrophage extracellular traps impair intestinal barrier function in DSS-induced colitis in mice by inducing intestinal epithelial cell apoptosis. [Abstract]2025 Dec;242(Pt 3):117406. PMID: 41057125 -
Biochem Pharmacol
2024 Jan:219:115957. PMID: 38049007 -
Virulence
Newcastle disease virus acquires phosphatidylserine through the budding process to enhance infectivity. [Abstract]2025 Oct 28:2580150. PMID: 41147668 -
J Ethnopharmacol
Shen-Qi-Jiang-Tang granule ameliorates diabetic nephropathy via modulating tumor necrosis factor signaling pathway. [Abstract]2023 Mar 1:303:116031. PMID: 36503032
Ionomycin calcium purchased from MedChemExpress. Usage Cited in: J Ethnopharmacol. 2023 Mar 1:303:116031. [Abstract]
Calcium imaging in HEK293T cells expressing E649A, E652K, and E652D mutants responds to 10 nM capsaicin, the cocktail of 10 nM capsaicin and 30 μM s-RhTx, 10 μM capsaicin, and 10 μM Ionomycin, respectively.
-
PLoS Pathog
The B169L protein of African swine fever virus functions as a viroporin that activates the calcium-mediated inflammasome. [Abstract]2025 Nov 14;21(11):e1013686. PMID: 41237200 -
Int J Mol Sci
Pro-Resolving Macrophage-Induced IL-35+ but Not TGF-β1+ Regulatory B Cell Activation Requires the PD-L1/PD-1 Pathway. [Abstract]2025 Jun 1;26(11):5332. PMID: 40508140 -
Int J Mol Sci
CD71-Mediated Effects of Soluble Vasorin on Tumor Progression, Angiogenesis and Immunosuppression. [Abstract]2025 May 20;26(10):4913. PMID: 40430053 -
PLoS Pathog
2025 Feb 4;21(2):e1012912. PMID: 39903705 -
Int J Mol Sci
IL-21/IL-21R Promotes the Pro-Inflammatory Effects of Macrophages during C. muridarum Respiratory Infection. [Abstract]2023 Aug 8;24(16):12557. PMID: 37628738 -
Int Immunopharmacol
H3K4 methylation of CALB2 facilitates immune evasion and chemoradiotherapy resistance in cholangiocarcinoma through KRT7-mediated PD-L1 upregulation. [Abstract]2026 Jun 15:179:116583. PMID: 41936307 -
Int Immunopharmacol
UBE2C-PI3K/AKT-mediated upregulation of MTHFD2 promotes tumor progression in hepatocellular carcinoma. [Abstract]2025 Dec 27:170:116081. PMID: 41456492 -
Int Immunopharmacol
2026 Jan 1;168(Pt 1):115803. PMID: 41218583 -
Int Immunopharmacol
Metformin alleviates inflammatory responses in acute allergic asthma by inhibiting ILC2s function. [Abstract]2025 May 20:159:114897. PMID: 40398255 -
Int Immunopharmacol
2024 Sep 16;142(Pt B):113170. PMID: 39288626 -
Int Immunopharmacol
Fecal microbiota transplantation regulates the microbiota-gut-spinal cord axis to promote recovery after spinal cord injury. [Abstract]2024 Jan 5:126:111212. PMID: 37979452 -
Int Immunopharmacol
Tespa1 deficiency reduces the antitumour immune response by decreasing CD8+T cell activity in a mouse Lewis lung cancer model. [Abstract]2023 Sep 1;124(Pt A):110865. PMID: 37660596 -
Eur J Pharmacol
Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice. [Abstract]2022 Feb 5:916:174623. PMID: 34767782 -
Microorganisms
CCR2 Enhances Anti-Intracellular Bacterial Infection by Modulating Macrophage Pyroptosis to Rebalance Th Immune Responses. [Abstract]2026 Jun 15;14(6):1339. PMID: 42354963 -
J Cell Mol Med
RTP4 Suppresses Colorectal Cancer Progression via MHC-I-Mediated CD8+ T Cell Infiltration and Enhances Immunotherapy Response. [Abstract]2025 Oct;29(20):e70915. PMID: 41126439 -
J Cell Mol Med
Iloprost Concentration-Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity. [Abstract]2025 Feb;29(3):e70403. PMID: 39929746 -
J Cell Mol Med
Aqueous extract of Descuraniae Semen attenuates lipopolysaccharide-induced inflammation by inhibiting ER stress and WNK4-SPAK-NKCC1 pathway. [Abstract]2024 Aug;28(15):e18589. PMID: 39135202 -
Microorganisms
IL-27 Signaling Promotes Th1 Response by Downregulating IL-10 Production in DCs during Chlamydial Respiratory Infection. [Abstract]2023 Feb 27;11(3):604. PMID: 36985179 -
J Inflamm Res
Interleukin-27 and Interleukin-2 Cooperatively Regulate CD4⁺ T Cell Subsets and Immune Imbalance in Coronary Artery Disease. [Abstract]2025 Dec 10:18:17253-17269. PMID: 41399529 -
iScience
AF6 regulates intestinal IgA via crosstalk between intestinal epithelial cells and immune cells in inflammatory bowel disease. [Abstract]2025 May 13;28(7):112658. PMID: 40687779 -
Cell Calcium
A NOX2-independent mechanism of Hv1 channel activation promotes inflammatory cytokine release from BV-2 microglia via intracellular Ca2+ mobilisation. [Abstract]2026 Mar:134:103122. PMID: 41581267 -
Cell Calcium
Mechanosensitive Piezo1 channel in rat epididymal epithelial cells promotes transepithelial K+ secretion. [Abstract]2022 Jun;104:102571. PMID: 35314382 -
Sci Rep
Molecular mechanism of LRRC15 protein regulating Treg/Th17 cell imbalance through the PI3K/Akt/mTORC1 signaling pathway in Taenia solium cysticercus infection. [Abstract]2026 Jun 3. PMID: 42230712 -
Fish Shellfish Immunol
Transcription factor networks drive perforin activity in the anti-bacterial immune response of tilapia. [Abstract]2024 Nov:154:109975. PMID: 39427837 -
Fish Shellfish Immunol
Inducible IL-2 production and IL-2+ cell expansion are landmark events for T-cell activation of teleost. [Abstract]2024 May:148:109515. PMID: 38499218 -
Oncol Rep
Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway. [Abstract]2024 Feb;51(2):29. PMID: 38131250 -
Aging
Transfer of exosomal microRNA-203-3p from dendritic cells to bone marrow-derived macrophages reduces development of atherosclerosis by downregulating Ctss in mice. [Abstract]2021 Jun 2;13(11):15638-15658. PMID: 34077394 -
Aging (Albany NY)
Membrane-cytoplasm translocation of annexin A4 is involved in the metastasis of colorectal carcinoma. [Abstract]2021 Mar 24;13(7):10312-10325. PMID: 33761465 -
Aging
Down-regulation of Cav1.3 in auditory pathway promotes age-related hearing loss by enhancing calcium-mediated oxidative stress in male mice. [Abstract]2019 Aug 19;11(16):6490-6502. PMID: 31425146 -
J Periodontol
B10 cells regulate macrophage polarization to alleviate inflammation and bone loss in periodontitis. [Abstract]2025 Apr;96(4):355-368. PMID: 39210600 -
ACS Infect Dis
Alanyl-Glutamine (Ala-Gln) Ameliorates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by Regulating the Gut Microbiota, PI3K-Akt/NF-κB/STAT3 Signaling, and Associated Pulmonary Injury. [Abstract]2023 Apr 14;9(4):979-992. PMID: 36917734 -
J Cell Sci
Non-muscle myosin IIA and IIB differentially affect the traffic and signalling of the thrombopoietin receptor. [Abstract]2025 Nov 17:jcs.264186. PMID: 41243451 -
Exp Cell Res
2026 Aug 1;461(1):115103. PMID: 42276196 -
Eur J Med Res
Invisible appliance promotes bone reconstruction via modulating the periodontal immune microenvironment. [Abstract]2025 May 12;30(1):378. PMID: 40350478 -
Vaccines
2023 May 25;11(6):1026. PMID: 37376415 -
J Immunol
The Anti-Inflammatory Immune Response in Early Trichinella spiralis Intestinal Infection Depends on Serine Protease Inhibitor-Mediated Alternative Activation of Macrophages. [Abstract]2021 Mar 1;206(5):963-977. PMID: 33495238 -
Vet Microbiol
Immunological characteristics of the recombinant pseudorabies virus with chimeric PCV Cap protein in pigs. [Abstract]2025 Apr 23:305:110529. PMID: 40288026 -
J Neuroimmunol
Matairesinol ameliorates experimental autoimmune uveitis by suppression of IRBP-specific Th17 cells. [Abstract]2020 Aug 15;345:577286. PMID: 32559555 -
Immunobiology
The role of CD24hiCD27+ regulatory B cells in human chronic rhinosinusitis with/without nasal polyps. [Abstract]2024 Nov;229(6):152854. PMID: 39340956 -
Arch Oral Biol
Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model. [Abstract]2024 Jul 3:166:106043. PMID: 38968906 -
-
Cytotechnology
Activation of MAL2 by RAD21 inhibits the expression of MHC-I in immune evasion of endometrial cancer. [Abstract]2024 Aug;76(4):465-482. PMID: 38933871 -
Cutan Ocul Toxicol
Leveraging a TRPV1-overexpressing cell model: an integrated testing strategy for UV filter-induced ocular irritation. [Abstract]2026 Jun;45(2):243-250. PMID: 41985167 -
Cell Insight
2026 Apr 2;5(3):100323. PMID: 42011339 -
-
-
-
-
-
-
Evid Based Complement Alternat Med
Cichoric Acid Ameliorates Monosodium Urate-Induced Inflammatory Response by Reducing NLRP3 Inflammasome Activation via Inhibition of NF- k B Signaling Pathway. [Abstract]2021 Jan 6:2021:8868527. PMID: 33505510
용액&용해도
DMSO : 50 mg/mL (66.93 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (3.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (3.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (271 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Liu C,et al. Characterization of ionomycin as a calcium ionophore. J Biol Chem. 1978 Sep 10;253(17):5892-4. [Content Brief]
[2]. Chatila T, et al. Mechanisms of T cell activation by the calcium ionophore ionomycin. J Immunol. 1989 Aug 15;143(4):1283-9. [Content Brief]
[3]. Gil-Parrado S, et al. Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem. 2002 Jul 26;277(30):27217-26. [Content Brief]
[4]. Stoeck A, et al A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J. 2006 Feb 1;393(Pt 3):609-18. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.3386 mL | 6.6928 mL | 13.3856 mL | 33.4641 mL |
| 5 mM | 0.2677 mL | 1.3386 mL | 2.6771 mL | 6.6928 mL | |
| 10 mM | 0.1339 mL | 0.6693 mL | 1.3386 mL | 3.3464 mL | |
| 15 mM | 0.0892 mL | 0.4462 mL | 0.8924 mL | 2.2309 mL | |
| 20 mM | 0.0669 mL | 0.3346 mL | 0.6693 mL | 1.6732 mL | |
| 25 mM | 0.0535 mL | 0.2677 mL | 0.5354 mL | 1.3386 mL | |
| 30 mM | 0.0446 mL | 0.2231 mL | 0.4462 mL | 1.1155 mL | |
| 40 mM | 0.0335 mL | 0.1673 mL | 0.3346 mL | 0.8366 mL | |
| 50 mM | 0.0268 mL | 0.1339 mL | 0.2677 mL | 0.6693 mL | |
| 60 mM | 0.0223 mL | 0.1115 mL | 0.2231 mL | 0.5577 mL |
Ionomycin calcium Related Classifications
HY-13434A Related Classifications
Powered by Bioz